A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)
Clinical trial NCT04519658 · COMPLETED
Trial details
- NCT number
- NCT04519658
- Sponsor
- CinCor Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-12
- Primary completion
- 2022-06-14
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.